Pub Date : 2026-02-09DOI: 10.1016/j.jcjo.2025.12.010
Tianwei Ellen Zhou, Peter John Kertes, Nasrin Najm-Tehrani, Kamiar Mireskandari
Purpose: Retinopathy of prematurity (ROP) is the leading cause of childhood blindness worldwide. While choroidal involution has been described in animal models, choroidal perfusion in premature infants remains poorly characterized because of limited use of intravenous fluorescein angiography (IVFA).
Methods: This retrospective study systematically analyzed IVFAs performed post-treatment in patients with ROP at the Hospital for Sick Children between 2011 and 2020. Eligible patients had received intravitreal bevacizumab or laser photocoagulation, and only transiting eyes were included to allow complete IVFA phase analysis. Three independent experts graded each IVFA for image quality, presence of delayed choroidal perfusion during the arteriovenous phase, and its location (central, peripheral, or multifocal). Inter-rater reliability was assessed using Fleiss's κ.
Results: Of 79 IVFAs reviewed, 74 met quality criteria. The cohort had an average birth weight of 602.6 g and a gestational age of 24.0 weeks. Most (63.5%) had zone I, stage 3+ ROP. IVFAs were conducted at a corrected age of 7.5 months. Delayed choroidal perfusion was found in 64 eyes (86.5%), predominantly multifocal. Only 2 eyes had normal perfusion. Inter-rater agreement was high (κ = 0.85).
Conclusions: Delayed choroidal perfusion is common and persistent in treated ROP patients. To our knowledge, this is the largest IVFA series that systematically describes this underrecognized feature with implications for long-term vision.
{"title":"Delayed choroidal perfusion: a fluorescein angiographic finding in retinopathy of prematurity.","authors":"Tianwei Ellen Zhou, Peter John Kertes, Nasrin Najm-Tehrani, Kamiar Mireskandari","doi":"10.1016/j.jcjo.2025.12.010","DOIUrl":"10.1016/j.jcjo.2025.12.010","url":null,"abstract":"<p><strong>Purpose: </strong>Retinopathy of prematurity (ROP) is the leading cause of childhood blindness worldwide. While choroidal involution has been described in animal models, choroidal perfusion in premature infants remains poorly characterized because of limited use of intravenous fluorescein angiography (IVFA).</p><p><strong>Methods: </strong>This retrospective study systematically analyzed IVFAs performed post-treatment in patients with ROP at the Hospital for Sick Children between 2011 and 2020. Eligible patients had received intravitreal bevacizumab or laser photocoagulation, and only transiting eyes were included to allow complete IVFA phase analysis. Three independent experts graded each IVFA for image quality, presence of delayed choroidal perfusion during the arteriovenous phase, and its location (central, peripheral, or multifocal). Inter-rater reliability was assessed using Fleiss's κ.</p><p><strong>Results: </strong>Of 79 IVFAs reviewed, 74 met quality criteria. The cohort had an average birth weight of 602.6 g and a gestational age of 24.0 weeks. Most (63.5%) had zone I, stage 3+ ROP. IVFAs were conducted at a corrected age of 7.5 months. Delayed choroidal perfusion was found in 64 eyes (86.5%), predominantly multifocal. Only 2 eyes had normal perfusion. Inter-rater agreement was high (κ = 0.85).</p><p><strong>Conclusions: </strong>Delayed choroidal perfusion is common and persistent in treated ROP patients. To our knowledge, this is the largest IVFA series that systematically describes this underrecognized feature with implications for long-term vision.</p>","PeriodicalId":9606,"journal":{"name":"Canadian journal of ophthalmology. Journal canadien d'ophtalmologie","volume":" ","pages":""},"PeriodicalIF":2.8,"publicationDate":"2026-02-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145910507","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-09DOI: 10.1016/j.jcjo.2026.01.003
Furkan Ozer, Hidayet Sener, Metin Unlu, Hatice Kübra Sönmez, Fatih Horozoglu, Cem Evereklioglu
Purpose: To systematically review the extant literature on pediatric endoscopic dacryocystorhinostomy (endoDCR) and to perform a meta-analysis of the pooled success rate and complication profile.
Methods: A comprehensive literature search was conducted using PubMed, Cochrane Library, and Web of Science databases in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Studies were included if they reported the pediatric endoDCR success rate with a minimum follow-up of 3 months and at least 10 patients. Data on success rates, complications, age, follow-up time, and silicone stent removal time were extracted. Statistical analyses were performed using comprehensive meta-analysis software.
Results: Twenty-nine studies comprising 1502 pediatric eyes were included. The pooled success rate was 87% (95% CI: 0.83-0.90). The I² statistic was 58.47%, indicating moderate to substantial heterogeneity. Egger's test indicated significant publication bias (p < 0.00001). Complication rates varied considerably: while some studies reported minor complications in up to 60% of cases, others documented serious, but rare, events such as cerebrospinal fluid rhinorrhea (0.28%). The most common complications included bleeding/epistaxis, tube prolapse, adhesions/synechiae, and granulation tissue.
Conclusion: EndoDCR is an effective and generally safe surgical option for pediatric nasolacrimal duct obstruction, with a high pooled success rate and acceptable variability in outcomes. However, variation in complication reporting and methodological heterogeneity across studies highlights the need for standardization in future research.
目的:系统地回顾现有的儿童内窥镜泪囊鼻腔造口术(endoDCR)的文献,并对合并成功率和并发症进行荟萃分析。方法:采用PubMed、Cochrane图书馆和Web of Science数据库,按照系统评价和meta分析指南的首选报告项目进行全面的文献检索。如果研究报告了至少随访3个月和至少10例患者的儿科endoDCR成功率,则纳入研究。提取了成功率、并发症、年龄、随访时间和硅胶支架取出时间的数据。采用综合元分析软件进行统计分析。结果:纳入29项研究,包括1502只儿童眼睛。合并成功率为87% (95% CI: 0.83-0.90)。I²统计量为58.47%,异质性中等至显著。Egger’s检验显示显著的发表偏倚(p < 0.00001)。并发症发生率差异很大:一些研究报告高达60%的病例出现轻微并发症,其他研究记录了严重但罕见的事件,如脑脊液鼻漏(0.28%)。最常见的并发症包括出血/鼻出血、管脱垂、粘连/粘连和肉芽组织。结论:EndoDCR是治疗小儿鼻泪管阻塞的一种有效且安全的手术选择,具有较高的总成功率和可接受的结果可变性。然而,并发症报告的差异和研究方法的异质性突出了未来研究标准化的必要性。
{"title":"Endoscopic dacryocystorhinostomy in the pediatric population: a systematic review and meta-analysis.","authors":"Furkan Ozer, Hidayet Sener, Metin Unlu, Hatice Kübra Sönmez, Fatih Horozoglu, Cem Evereklioglu","doi":"10.1016/j.jcjo.2026.01.003","DOIUrl":"10.1016/j.jcjo.2026.01.003","url":null,"abstract":"<p><strong>Purpose: </strong>To systematically review the extant literature on pediatric endoscopic dacryocystorhinostomy (endoDCR) and to perform a meta-analysis of the pooled success rate and complication profile.</p><p><strong>Methods: </strong>A comprehensive literature search was conducted using PubMed, Cochrane Library, and Web of Science databases in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Studies were included if they reported the pediatric endoDCR success rate with a minimum follow-up of 3 months and at least 10 patients. Data on success rates, complications, age, follow-up time, and silicone stent removal time were extracted. Statistical analyses were performed using comprehensive meta-analysis software.</p><p><strong>Results: </strong>Twenty-nine studies comprising 1502 pediatric eyes were included. The pooled success rate was 87% (95% CI: 0.83-0.90). The I² statistic was 58.47%, indicating moderate to substantial heterogeneity. Egger's test indicated significant publication bias (p < 0.00001). Complication rates varied considerably: while some studies reported minor complications in up to 60% of cases, others documented serious, but rare, events such as cerebrospinal fluid rhinorrhea (0.28%). The most common complications included bleeding/epistaxis, tube prolapse, adhesions/synechiae, and granulation tissue.</p><p><strong>Conclusion: </strong>EndoDCR is an effective and generally safe surgical option for pediatric nasolacrimal duct obstruction, with a high pooled success rate and acceptable variability in outcomes. However, variation in complication reporting and methodological heterogeneity across studies highlights the need for standardization in future research.</p>","PeriodicalId":9606,"journal":{"name":"Canadian journal of ophthalmology. Journal canadien d'ophtalmologie","volume":" ","pages":""},"PeriodicalIF":2.8,"publicationDate":"2026-02-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146060099","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-05DOI: 10.1016/j.jcjo.2025.12.024
Salome Akhvlediani, Rolika Bansal, Robert T Swan, Carol L Shields
{"title":"DICER-1 pigmented ciliary body medulloepithelioma diagnosed secondary to cyclitic membrane adherent to intraocular lens.","authors":"Salome Akhvlediani, Rolika Bansal, Robert T Swan, Carol L Shields","doi":"10.1016/j.jcjo.2025.12.024","DOIUrl":"10.1016/j.jcjo.2025.12.024","url":null,"abstract":"","PeriodicalId":9606,"journal":{"name":"Canadian journal of ophthalmology. Journal canadien d'ophtalmologie","volume":" ","pages":""},"PeriodicalIF":2.8,"publicationDate":"2026-02-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146046126","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-03DOI: 10.1016/j.jcjo.2026.01.001
Changseok Lee, Devin Betsch, Arif Samad
{"title":"Vitreous occlusion of Ahmed glaucoma valve.","authors":"Changseok Lee, Devin Betsch, Arif Samad","doi":"10.1016/j.jcjo.2026.01.001","DOIUrl":"10.1016/j.jcjo.2026.01.001","url":null,"abstract":"","PeriodicalId":9606,"journal":{"name":"Canadian journal of ophthalmology. Journal canadien d'ophtalmologie","volume":" ","pages":""},"PeriodicalIF":2.8,"publicationDate":"2026-02-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146046110","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-03DOI: 10.1016/j.jcjo.2025.11.009
Eknoor Padda, Mehrshad Hanafimosalman, Louis Racine, Samir Jabbour, Patrick Daigle, Erika Massicotte, Mona Harissi-Dagher, Laura Segal, Marie-Claude Robert
Objective: To evaluate the real-world effectiveness and safety of topical insulin (25 IU/mL) in patients with neurotrophic keratopathy (NK) across multiple etiologies.
Methods: We retrospectively reviewed 29 consecutive eyes of 28 patients with neurotrophic keratopathy treated with topical insulin at a single center. The primary outcome was complete epithelial healing for stages 2 and 3 NK; for stage 1, success was prespecified as improvement in corneal staining and epithelial integrity. Statistical analysis included survival analysis and multivariable logistic regression with Firth penalization.
Results: Twenty-nine eyes with a mean follow-up of 32.7 weeks were included. Most common etiologies were infectious (51.7%), including herpes simplex virus (24.1%) and varicella zoster virus (20.7%). Twenty-three eyes had stages 2 or 3 NK. Among eyes with stages 2 and 3 NK, complete epithelial healing occurred in 18/23 (78.3%, 95%; CI: 58.1-90.3%), with a median healing time of 33.5 days (IQR: 15.8-81.8). The cumulative healing rate at 8 weeks was 43.5%. Healing success was not significantly associated with defect size or etiology. Among 8 patients who discontinued insulin after healing, recurrence occurred in 1 case (12.5%) and resolved upon treatment resumption. One patient developed mild punctate keratopathy that resolved with continued therapy.
Conclusions: Topical insulin demonstrated substantial healing efficacy for neurotrophic keratopathy across diverse etiologies, with a favourable safety profile and low recurrence rate. Although healing may be slower than FDA-approved alternatives, the dramatic cost difference suggests insulin may be a cost-effective first-line therapy for refractory cases. This represents one of the largest multietiological case series of insulin therapy for neurotrophic keratopathy reported to date.
{"title":"Real-world effectiveness of topical insulin for neurotrophic keratopathy: retrospective case series of 29 eyes.","authors":"Eknoor Padda, Mehrshad Hanafimosalman, Louis Racine, Samir Jabbour, Patrick Daigle, Erika Massicotte, Mona Harissi-Dagher, Laura Segal, Marie-Claude Robert","doi":"10.1016/j.jcjo.2025.11.009","DOIUrl":"10.1016/j.jcjo.2025.11.009","url":null,"abstract":"<p><strong>Objective: </strong>To evaluate the real-world effectiveness and safety of topical insulin (25 IU/mL) in patients with neurotrophic keratopathy (NK) across multiple etiologies.</p><p><strong>Methods: </strong>We retrospectively reviewed 29 consecutive eyes of 28 patients with neurotrophic keratopathy treated with topical insulin at a single center. The primary outcome was complete epithelial healing for stages 2 and 3 NK; for stage 1, success was prespecified as improvement in corneal staining and epithelial integrity. Statistical analysis included survival analysis and multivariable logistic regression with Firth penalization.</p><p><strong>Results: </strong>Twenty-nine eyes with a mean follow-up of 32.7 weeks were included. Most common etiologies were infectious (51.7%), including herpes simplex virus (24.1%) and varicella zoster virus (20.7%). Twenty-three eyes had stages 2 or 3 NK. Among eyes with stages 2 and 3 NK, complete epithelial healing occurred in 18/23 (78.3%, 95%; CI: 58.1-90.3%), with a median healing time of 33.5 days (IQR: 15.8-81.8). The cumulative healing rate at 8 weeks was 43.5%. Healing success was not significantly associated with defect size or etiology. Among 8 patients who discontinued insulin after healing, recurrence occurred in 1 case (12.5%) and resolved upon treatment resumption. One patient developed mild punctate keratopathy that resolved with continued therapy.</p><p><strong>Conclusions: </strong>Topical insulin demonstrated substantial healing efficacy for neurotrophic keratopathy across diverse etiologies, with a favourable safety profile and low recurrence rate. Although healing may be slower than FDA-approved alternatives, the dramatic cost difference suggests insulin may be a cost-effective first-line therapy for refractory cases. This represents one of the largest multietiological case series of insulin therapy for neurotrophic keratopathy reported to date.</p>","PeriodicalId":9606,"journal":{"name":"Canadian journal of ophthalmology. Journal canadien d'ophtalmologie","volume":" ","pages":""},"PeriodicalIF":2.8,"publicationDate":"2026-02-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145843160","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-02DOI: 10.1016/j.jcjo.2025.12.005
Syed Ahmad, Changseok Lee, John Dickinson
{"title":"Bilateral sequential endogenous endophthalmitis due to Streptococcus pyogenes: case report and literature review.","authors":"Syed Ahmad, Changseok Lee, John Dickinson","doi":"10.1016/j.jcjo.2025.12.005","DOIUrl":"10.1016/j.jcjo.2025.12.005","url":null,"abstract":"","PeriodicalId":9606,"journal":{"name":"Canadian journal of ophthalmology. Journal canadien d'ophtalmologie","volume":" ","pages":""},"PeriodicalIF":2.8,"publicationDate":"2026-02-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145818080","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-02DOI: 10.1016/j.jcjo.2025.12.014
Jeffrey M Mah, Meghan McConnell, Kaisra Esmail, Irfan N Kherani, Stephanie A Baxter, Bernard R Hurley, Michael D O'Connor, Chloe C Gottlieb
Objective: To develop a surgical assessment tool to evaluate the breadth of surgical procedures in which ophthalmology residents are required to gain competence and to validate this tool for cataract surgery.
Design: A questionnaire development study.
Participants: Ophthalmology residents and faculty at the University of Ottawa.
Methods: The Canadian Ophthalmology Assessment Tool for Surgery (COATS) was developed by a group of experts by modifying a previously validated assessment tool, the Ottawa Surgical Competency Operating Room Evaluation, and consists of 6 Likert scale items, 1 yes or no question assessing independence and 2 open-ended questions for narrative feedback. During a 2-year period, residents were evaluated on the performance of cataract surgery using the COATS. The primary outcome was the total COATS score, defined as the sum of the Likert scale items.
Results: A total of 165 COATS assessments were collected across 5 residents. Mean total COATS scores were lower for the first 2 months of training compared with the last 3 months of training (4.33 ± 0.25 vs 4.81 ± 0.03; p = 0.01; Cohen's d = 0.25) and for procedures where the resident was rated as "not independent" versus "independent" (4.26 ± 0.13 vs 4.74 ± 0.06; p = 0.006; Cohen's d = 0.13). There was a significant correlation between the number of cataract surgeries performed and the mean total COATS score (Pearson r = 0.20; p = 0.02). Forty-five COATS assessments per resident were required to obtain an overall reliability of 0.70, the accepted threshold for low-stakes assessments.
Conclusions: The COATS is a valid tool for the assessment of surgical competence in cataract surgery. There is also evidence that it is a reliable tool when completed multiple times per resident over the course of training.
目的:开发一种外科评估工具,以评估眼科住院医师需要获得能力的外科手术的广度,并验证该工具用于白内障手术的有效性。设计:问卷开发研究。参与者:渥太华大学眼科住院医师和教职员工。方法:加拿大眼科手术评估工具(COATS)由一组专家通过修改先前有效的评估工具渥太华手术能力手术室评估而开发,由6个李克特量表项目组成,1个是或否问题评估独立性,2个开放式问题用于叙述性反馈。在2年的时间里,住院医师使用COATS对白内障手术的表现进行了评估。主要结果是COATS总分,定义为李克特量表项目的总和。结果:共收集了5名居民的165份COATS评估。前2个月的平均总COATS评分低于后3个月的平均总COATS评分(4.33±0.25 vs 4.81±0.03;p = 0.01;Cohen's d = 0.25),住院医师被评为“不独立”与“独立”的程序(4.26±0.13 vs 4.74±0.06;p = 0.006;Cohen's d = 0.13)。白内障手术次数与平均总COATS评分有显著相关性(Pearson r = 0.20;p = 0.02)。每位居民需要进行45次COATS评估,才能获得0.70的总体可靠性,这是低利害关系评估的公认阈值。结论:COATS是评估白内障手术能力的有效工具。也有证据表明,如果在培训过程中每个住院医师完成多次,它是一个可靠的工具。
{"title":"The Canadian ophthalmology assessment tool for surgery: a surgical assessment tool for ophthalmology training programs.","authors":"Jeffrey M Mah, Meghan McConnell, Kaisra Esmail, Irfan N Kherani, Stephanie A Baxter, Bernard R Hurley, Michael D O'Connor, Chloe C Gottlieb","doi":"10.1016/j.jcjo.2025.12.014","DOIUrl":"10.1016/j.jcjo.2025.12.014","url":null,"abstract":"<p><strong>Objective: </strong>To develop a surgical assessment tool to evaluate the breadth of surgical procedures in which ophthalmology residents are required to gain competence and to validate this tool for cataract surgery.</p><p><strong>Design: </strong>A questionnaire development study.</p><p><strong>Participants: </strong>Ophthalmology residents and faculty at the University of Ottawa.</p><p><strong>Methods: </strong>The Canadian Ophthalmology Assessment Tool for Surgery (COATS) was developed by a group of experts by modifying a previously validated assessment tool, the Ottawa Surgical Competency Operating Room Evaluation, and consists of 6 Likert scale items, 1 yes or no question assessing independence and 2 open-ended questions for narrative feedback. During a 2-year period, residents were evaluated on the performance of cataract surgery using the COATS. The primary outcome was the total COATS score, defined as the sum of the Likert scale items.</p><p><strong>Results: </strong>A total of 165 COATS assessments were collected across 5 residents. Mean total COATS scores were lower for the first 2 months of training compared with the last 3 months of training (4.33 ± 0.25 vs 4.81 ± 0.03; p = 0.01; Cohen's d = 0.25) and for procedures where the resident was rated as \"not independent\" versus \"independent\" (4.26 ± 0.13 vs 4.74 ± 0.06; p = 0.006; Cohen's d = 0.13). There was a significant correlation between the number of cataract surgeries performed and the mean total COATS score (Pearson r = 0.20; p = 0.02). Forty-five COATS assessments per resident were required to obtain an overall reliability of 0.70, the accepted threshold for low-stakes assessments.</p><p><strong>Conclusions: </strong>The COATS is a valid tool for the assessment of surgical competence in cataract surgery. There is also evidence that it is a reliable tool when completed multiple times per resident over the course of training.</p>","PeriodicalId":9606,"journal":{"name":"Canadian journal of ophthalmology. Journal canadien d'ophtalmologie","volume":" ","pages":""},"PeriodicalIF":2.8,"publicationDate":"2026-02-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145958814","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-02DOI: 10.1016/j.jcjo.2025.12.008
Tala O Radi, Cynthia L Larche, Austin Pereira, Tina Tang, Larissa Derzko-Dzulynsky, Nupura Bakshi, Alexander J Kaplan, Peng Yan
Objective: To synthesize and critically appraise the available evidence on choroidal vitiligo, integrating clinical presentation, multimodal imaging characteristics, and diagnostic differentiation from mimics, while proposing a set of diagnostic criteria based on literature synthesis and authors' expert consensus.
Methods: A systematic search of PubMed, Embase, and Cochrane Reviews through July 2025 identified English-language studies reporting on choroidal vitiligo. Two reviewers independently screened, extracted data, and assessed methodological quality for case reports and case series. Narrative synthesis and descriptive statistics were used to summarize the findings.
Results: Eight studies met inclusion criteria, comprising 16 patients (28 eyes) from 5 countries. The majority of patients (75%) were asymptomatic, middle-aged females, with bilateral involvement in 88% of cases and preserved visual acuity (≥20/25 in 81% of eyes). Multimodal imaging consistently revealed well-demarcated choroidal hypopigmentation with intact retinal architecture and no intraocular inflammation. OCT demonstrated preserved retinal layers with occasional mild choroidal thinning. Fundus autofluorescence often showed scleral hyper-autofluorescence; FA/indocyanine green angiography showed mild window defects without leakage. Cutaneous vitiligo was present in 63% of patients, with no systemic autoimmune disease reported.
Conclusions: Choroidal vitiligo is a rare, benign, and often incidental finding, best recognized through multimodal imaging. This review proposes clinical diagnostic criteria for primary choroidal vitiligo and highlights its key imaging signature to aid differentiation from neoplastic and inflammatory mimics. We recommend baseline multimodal imaging and follow-up at 6-12 months to confirm stability. Standardized imaging criteria and prospective studies are needed to better define prevalence, natural history, and systemic associations. Given that most included studies were single-case reports, the overall level of evidence is low.
{"title":"Choroidal vitiligo: systematic review of imaging findings, clinical presentation, and diagnostic considerations.","authors":"Tala O Radi, Cynthia L Larche, Austin Pereira, Tina Tang, Larissa Derzko-Dzulynsky, Nupura Bakshi, Alexander J Kaplan, Peng Yan","doi":"10.1016/j.jcjo.2025.12.008","DOIUrl":"10.1016/j.jcjo.2025.12.008","url":null,"abstract":"<p><strong>Objective: </strong>To synthesize and critically appraise the available evidence on choroidal vitiligo, integrating clinical presentation, multimodal imaging characteristics, and diagnostic differentiation from mimics, while proposing a set of diagnostic criteria based on literature synthesis and authors' expert consensus.</p><p><strong>Methods: </strong>A systematic search of PubMed, Embase, and Cochrane Reviews through July 2025 identified English-language studies reporting on choroidal vitiligo. Two reviewers independently screened, extracted data, and assessed methodological quality for case reports and case series. Narrative synthesis and descriptive statistics were used to summarize the findings.</p><p><strong>Results: </strong>Eight studies met inclusion criteria, comprising 16 patients (28 eyes) from 5 countries. The majority of patients (75%) were asymptomatic, middle-aged females, with bilateral involvement in 88% of cases and preserved visual acuity (≥20/25 in 81% of eyes). Multimodal imaging consistently revealed well-demarcated choroidal hypopigmentation with intact retinal architecture and no intraocular inflammation. OCT demonstrated preserved retinal layers with occasional mild choroidal thinning. Fundus autofluorescence often showed scleral hyper-autofluorescence; FA/indocyanine green angiography showed mild window defects without leakage. Cutaneous vitiligo was present in 63% of patients, with no systemic autoimmune disease reported.</p><p><strong>Conclusions: </strong>Choroidal vitiligo is a rare, benign, and often incidental finding, best recognized through multimodal imaging. This review proposes clinical diagnostic criteria for primary choroidal vitiligo and highlights its key imaging signature to aid differentiation from neoplastic and inflammatory mimics. We recommend baseline multimodal imaging and follow-up at 6-12 months to confirm stability. Standardized imaging criteria and prospective studies are needed to better define prevalence, natural history, and systemic associations. Given that most included studies were single-case reports, the overall level of evidence is low.</p>","PeriodicalId":9606,"journal":{"name":"Canadian journal of ophthalmology. Journal canadien d'ophtalmologie","volume":" ","pages":""},"PeriodicalIF":2.8,"publicationDate":"2026-02-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145942591","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}